LUIS
BRIEVA RUIZ
CON
![Foto de LUIS](/img/nophoto.png)
![Foto de Universidad Autónoma de Madrid](/img/noimage_org.png)
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (5)
2023
-
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
2022
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
2021
-
High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions
Patient, Vol. 14, Núm. 2, pp. 241-248
-
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
Neurologia, Vol. 36, Núm. 1, pp. 50-60
2017
-
Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: Item response theory modelling and confirmatory factor analysis
Health and Quality of Life Outcomes, Vol. 15, Núm. 1